Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-08-206166
Filing Date
2008-10-06
Accepted
2008-10-03 20:29:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A dsc13da.htm SC 13D/A 31570
  Complete submission text file 0001193125-08-206166.txt   33877
Mailing Address 323 VINTAGE PARK DRIVE, SUITE B FOSTER CITY CA 94404
Business Address 323 VINTAGE PARK DRIVE, SUITE B FOSTER CITY CA 94404 6502122568
OXIS INTERNATIONAL INC (Subject) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-32837 | Film No.: 081108020
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858 623-5665 XT 158
TorreyPines Therapeutics, Inc. (Filed by) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations